Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
    about 19 hours ago
  • New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
    about 19 hours ago
  • I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
    about 2 days ago
  • Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
    about 3 days ago
  • A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
    about 3 days ago

Please share Science & Enterprise

Yom Kippur 5781

Shofar

We’re observing Yom Kippur today, the day of atonement and holiest day in the Jewish calendar. . . . → Read More: Yom Kippur 5781

Shana Tova 5781

Honey and paple

Science and Enterprise is taking off today to observe Rosh Hashanah, the Jewish new year. . . . → Read More: Shana Tova 5781

No Posts Today

Medical gear

The nation and the world aren’t the ones facing health issues., even intrepid business/science writers and editors. . . . → Read More: No Posts Today

Taking a Break

Photographer

We’re taking this week off at Science & Enterprise, to concentrate on a big photography project, and will return on 31 August. . . . → Read More: Taking a Break

Essay – Ten Years and Counting

4th of July fireworks

If you dig deep into the Science & Enterprise archives, you’ll find this site began posting on 6 July 2010, exactly 10 years ago today. . . . → Read More: Essay – Ten Years and Counting

Post removed

Sponsored post removed because of non-payment . . . → Read More: Post removed

Taking a Break

Suitcase in airport

We will return to our regular publishing on Wednesday, 4 March. . . . → Read More: Taking a Break

Post removed

Sponsored post removed because of non-payment. . . . → Read More: Post removed

Science & Enterprise Year in Review

Crispr explainer

Our most-viewed new story is from an academic/industry research team in Australia that tells how a synthetic cannabidiol, or CBD, compound is as effective as current antibiotics against a class of microbes. . . . → Read More: Science & Enterprise Year in Review

Happy Holidays 2019

Cardinal in snow

It’s Christmas day and a holiday in many countries around the world, including the U.S. . . . → Read More: Happy Holidays 2019